Skip to main content
. 2018 Sep 11;14:1691–1700. doi: 10.2147/TCRM.S173041

Table 2.

The efficacy of patients with advanced pancreatic cancer received PD-1/PD-L1 inhibitor

Response N (n = 38) Percentage
CR 0 0
PR 4 10.5
SD 15 39.5
PD 19 50.0
ORR 4 10.5
 95% CI 2.6–21.2
DCR 19 50.0
 95% CI 34.2–65.8

Abbreviations: CI, confidence interval; CR, complete remission; DCR, disease control rate; ORR, objective response rate; PD, progression of the disease; PR, partial remission; SD, stable disease.